KP Divya

Progressive Myoclonic Epilepsies – A Pragmatic Review

Ajith Cherian, KP Divya

INTRODUCTION: Progressive Myoclonus Epilepsy (PME) is a rare and complex group of inherited neurodegenerative disorders characterized by progressively worsening myoclonus, cognitive impairment, tonic-clonic seizures and ataxia. The clinical features and genetic underpinnings of PME are diverse, with approximately 80% of individuals now …

in (code pays fourni par la source)

COVID-19 pandemic and neurosciences in India – The coin study: Impact on neuroscience research and early career researchers

Samim Ali Mondal, Makarand Pantoji, KP Divya, Harsh Deora et autres

in (code pays fourni par la source)

Status Epilepticus in Coenzyme A Synthase Protein-Associated Neurodegeneration - Expanding the Clinical Phenotype

Valaparambil Karthika Ajit, Prabhu Selvaraj, KP Divya, Bejoy Thomas et autres

in (code pays fourni par la source)

Oromandibular Dystonia – A Systematic Review

Udit Umesh Saraf, Mitesh Chandarana, KP Divya, Syam Krishnan

Oromandibular dystonia (OMD) is a clinical problem which is commonly encountered in the practice of movement disorders. OMD results from a variety of genetic and acquired etiologies and can occur as an isolated manifestation, or as part of an isolated generalized or …

in (code pays fourni par la source)

Cognitive outcome following bilateral subthalamic nucleus deep brain stimulation for Parkinson’s disease—a comparative observational study in Indian patients

Kshiteeja Jain, Remya Ramesh, Syam Krishnan, Krishnakumar Kesavapisharady et autres

in (code pays fourni par la source)

“Emanating from Mastaba”

KP Divya

Just when the caterpillar thought it has been wound up into a mastaba, it became a butterfly.

in (code pays fourni par la source)

Cocooned in Covid

KP Divya

Figure 1: Cocooned in Covid

in (code pays fourni par la source)

Systemic chemotherapy and cognitive dysfunction in primary brain tumors – To incriminate or exculpate?

Thattungal Manoharan Anoop, KP Divya, Ajith Cherian

in (code pays fourni par la source)

210 CASPR2 antibody-related movement disorders: case series

Mei See, Varduhi Cahill, Sangeeta Scotton, Piers Newman et autres

Introduction Contactin-associated protein 2 (CASPR2) antibodies are implicated in the development of a spectrum of neurological conditions where movement disorders constitute a substantial part of the clinical manifestations along with behavioral and cognitive impairment. Case report We report a case series of …

gb, in (code pays fourni par la source)

Deep brain stimulation for movement disorders

Asha Kishore, Syam Krishnan, KrishnakumarKesava Pisharady, KP Divya et autres

Deep Brain Stimulation (DBS) was introduced into clinical practice nearly four decades ago and is currently the standard of care for patients with Parkinson's disease experiencing motor complications. Apart from this, it has several other established and emerging applications in movement disorders. …

in (code pays fourni par la source)

A hospital-based registry of Creutzfeldt–Jakob disease: Can neuroimaging serve as a surrogate biomarker?

Ramshekhar N Menon, KP Divya, Bejoy Thomas, Muralidharan Nair

AIM: This study addresses the role of neuroimaging in addition to the available clinical criteria for Creutzfeldt-Jakob disease (CJD) and its impact on its diagnosis in the absence of cerebrospinal fluid (CSF) biomarkers and tissue-based approaches. METHODS: From a tertiary referral center …

in (code pays fourni par la source)

A Comparison of Cognitive Profiles and Structural Correlates in Vascular and Non Vascular Mild Cognitive Impairment

KP Divya